| Sarcoma Diagnosis and Treatment | Lifetime | 4 | US 3 | 99.97 |
| Cardiac tumors and thrombi | Lifetime | 3 | US 3 | 99.96 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 7 | US 5 | 99.94 |
| Soft tissue tumor case studies | Lifetime | 3 | US 3 | 99.91 |
| Tumors and Oncological Cases | Lifetime | 3 | US 3 | 99.94 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 8 | US 5 | 99.89 |
| Vascular Tumors and Angiosarcomas | Lifetime | 4 | US 3 | 99.94 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 11 | US 11 | 99.78 |
| Oral and Maxillofacial Pathology | Lifetime | 46 | US 23 | 99.53 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 40 | US 23 | 99.51 |
| Soft tissue tumors and treatment | Lifetime | 7 | US 5 | 99.45 |
| Ear and Head Tumors | Lifetime | 46 | US 32 | 99.29 |
| Histiocytic Disorders and Treatments | Lifetime | 28 | US 16 | 98.96 |
| Cancer-related molecular mechanisms research | Lifetime | 493 | US 129 | 98.48 |
| Metastasis and carcinoma case studies | Lifetime | 196 | US 25 | 98.16 |
| Renal and related cancers | Lifetime | 269 | US 152 | 98.58 |
| Lymphoma Diagnosis and Treatment | Lifetime | 495 | US 236 | 98.73 |
| Cancer and Skin Lesions | Lifetime | 162 | US 85 | 98.42 |
| Gastric Cancer Management and Outcomes | Lifetime | 672 | US 213 | 98.63 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 104 | US 48 | 98.53 |
| Chromatin Remodeling and Cancer | Lifetime | 90 | US 51 | 97.39 |
| Gastrointestinal disorders and treatments | Lifetime | 711 | US 271 | 97.36 |
| Urologic and reproductive health conditions | Lifetime | 373 | US 197 | 97.74 |
| Vascular Malformations and Hemangiomas | Lifetime | 195 | US 109 | 96.32 |
| Renal cell carcinoma treatment | Lifetime | 913 | US 457 | 96.54 |
| Tuberous Sclerosis Complex Research | Lifetime | 156 | US 92 | 93.28 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 565 | US 129 | 86.14 |
| Cardiac tumors and thrombi | 2021-2025 | 2 | US 1 | 99.52 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 7 | US 2 | 99.67 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 3 | US 1 | 99.54 |
| Tumors and Oncological Cases | 2021-2025 | 6 | US 3 | 98.30 |
| Soft tissue tumor case studies | 2021-2025 | 6 | US 4 | 98.31 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 19 | US 15 | 97.60 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 25 | US 5 | 97.76 |
| Ear and Head Tumors | 2021-2025 | 42 | US 15 | 94.35 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 148 | US 22 | 95.25 |
| Chromatin Remodeling and Cancer | 2021-2025 | 42 | US 16 | 91.61 |
| Renal and related cancers | 2021-2025 | 308 | US 127 | 91.21 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 54 | US 25 | 85.36 |
| Gastrointestinal disorders and treatments | 2021-2025 | 650 | US 130 | 85.14 |
| Urologic and reproductive health conditions | 2021-2025 | 431 | US 97 | 83.61 |
| Uterine Myomas and Treatments | 2021-2025 | 675 | US 136 | 83.15 |
| Medical Imaging and Pathology Studies | 2021-2025 | 640 | US 191 | 78.81 |
| Vascular Malformations and Hemangiomas | 2021-2025 | 237 | US 79 | 79.82 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 718 | US 171 | 78.05 |
| Histiocytic Disorders and Treatments | 2021-2025 | 258 | US 104 | 65.92 |
